Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements - Narrative (Details)

v3.20.1
Fair Value Measurements - Narrative (Details)
 12 Months Ended
Nov. 01, 2019
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
class_of_stock
milestone
Dec. 31, 2018
USD ($)
class_of_stock
Dec. 31, 2017
USD ($)
Feb. 16, 2018
USD ($)
Nov. 17, 2017
USD ($)
Dec. 31, 2015
shares
Oct. 31, 2015
shares
Dec. 31, 2014
shares
Level 3 Valuation                  
Investment in Aytu   $ 7,628,947 $ 0            
Contingent consideration   0              
Change in fair value of contingent consideration   $ 1,256,211 $ 110,923            
Number of changes in valuation techniques | class_of_stock   0 0            
Amount of transfers of assets from level 2 to level 1   $ 0 $ 0            
Amount of transfers of assets from level 1 to level 2   0 0            
Common stock                  
Level 3 Valuation                  
Number of shares available under warrant (in shares) | shares               22,328  
Avadel                  
Level 3 Valuation                  
Product royalty 15.00%                
Royalty obligation $ 12,500,000                
Contingent consideration   0     $ 7,900,000        
TRx                  
Level 3 Valuation                  
Contingent consideration   $ 0       $ 1,366,633      
Number of contingent consideration milestones | milestone   2              
Milestone One | TRx                  
Level 3 Valuation                  
Contingent consideration     0     3,000,000      
Gross profit     12,600,000            
Milestone Two | TRx                  
Level 3 Valuation                  
Contingent consideration           2,000,000      
Milestone Three | TRx                  
Level 3 Valuation                  
Contingent consideration           $ 2,000,000      
Level 2                  
Level 3 Valuation                  
Investment in Aytu   $ 7,628,947 $ 0            
Level 3                  
Level 3 Valuation                  
Change in fair value of contingent consideration   $ (24,827)   $ 135,933          
Warrant liability | Level 3                  
Level 3 Valuation                  
Expected life   9 months 18 days              
Warrant liability | Level 3 | Measurement input share price (in dollars per share)                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input | $ / shares   5.39              
Warrant liability | Level 3 | Measurement input price volatility                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input   0.42              
Warrant liability | Level 3 | Measurement input risk free interest rate                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input   0.0159              
Warrant liability | Level 3 | Measurement input strike price (in dollars per share)                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input | $ / shares   8.40              
Unit purchase option liability | Level 3                  
Level 3 Valuation                  
Expected life   9 months 18 days              
Change in fair value of contingent consideration   $ (3,378)   $ 19,775          
Unit purchase option liability | Level 3 | Measurement input share price (in dollars per share)                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input | $ / shares   5.39              
Unit purchase option liability | Level 3 | Measurement input price volatility                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input   0.42              
Unit purchase option liability | Level 3 | Measurement input risk free interest rate                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input   0.0159              
Unit purchase option liability | Level 3 | Measurement input strike price (in dollars per share)                  
Level 3 Valuation                  
Warrants and rights outstanding measurement input | $ / shares   7.47              
Common Stock Warrants                  
Level 3 Valuation                  
Number of shares available under warrant (in shares) | shares             40,000    
Series B convertible preferred stock | Preferred Stock                  
Level 3 Valuation                  
Number of shares available under warrant (in shares) | shares                 625,208
Pediatric Portfolio | Convertible Preferred Stock                  
Level 3 Valuation                  
Shares received as consideration (in shares) | shares 9,805,845                
Shares received as consideration, price per share (in dollars per share) | $ / shares $ 1.2747                
AYTU | Convertible Preferred Stock | Level 2                  
Level 3 Valuation                  
Investment in Aytu $ 7,600,000 $ 7,600,000              
AYTU | Convertible Preferred Stock | Level 2 | Measurement input share price (in dollars per share)                  
Level 3 Valuation                  
Equity securities, measurement input | $ / shares 1.03 0.9725              
AYTU | Convertible Preferred Stock | Level 2 | Measurement input, discount for lack of marketability                  
Level 3 Valuation                  
Equity securities, measurement input 0.25 0.20              
Ulesfia Supply Agreement                  
Level 3 Valuation                  
Change in fair value of contingent consideration   $ (1,300,000)              
Ulesfia Supply Agreement | Level 3                  
Level 3 Valuation                  
Change in fair value of contingent consideration   1,300,000              
Flexichamber | Level 3                  
Level 3 Valuation                  
Impairment of intangible assets   $ 1,400,000